Evidence based case report should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy 原发性脑出血患者是否应该进行抗血小板或抗凝治疗
Anticoagulation use has increased in nontargeted , low - risk groups in whom antiplatelet agents are appropriate 在那些接受抗血小板治疗更加合适的低危险组病人中,抗凝治疗的使用也呈增加趋势。
It is well recognized that antiplatelet therapy is effective in the prevention and treatment of thrombosis 摘要抗血小板治疗可以有效预防和治疗血栓性疾病,氯吡格雷是一种新型安全高效的抗血小板药物。
Hence , particularly for women at high risk of preeclampsia , a more widespread use of antiplatelet agents may be worthwhile , " she said 因此,特别是对于她们来说,更广泛地应用抗血小板药物是值得的。 ”
The researchers found the risks of developing preeclampsia dropped 10 percent among women taking aspirin or other antiplatelet medications 研究者发现,相比于服用阿司匹林或者其它抗血小板药物,患先兆子痫的概率下降了10 % 。